| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377309A1 Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
| 01/07/2004 | EP1377308A1 Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock |
| 01/07/2004 | EP1377306A1 Serum albumin binding moieties |
| 01/07/2004 | EP1377305A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/07/2004 | EP1377304A2 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 01/07/2004 | EP1377303A2 Method for reducing cellular damage resulting from hypoxia/ischaemia-related inflammation |
| 01/07/2004 | EP1377302A1 Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377298A2 Combined method for treating hormono-dependent disorders |
| 01/07/2004 | EP1377279A2 Inhibition of erk to reduce or prevent tolerance to and dependence on opioid analgesics |
| 01/07/2004 | EP1377253A1 Methods of preventing uvb-induced skin damage |
| 01/07/2004 | EP1377251A2 A cell therapy method for the treatment of tumors |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | EP1227736B1 Protein hydrolysates produced with the use of marine proteases |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0920326B1 Use of a bpi protein product as an antithrombotic agent |
| 01/07/2004 | EP0857081B1 Preparation of peptide containing biodegradable microspheres by melt process |
| 01/07/2004 | EP0724436B1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1465704A Cancer suppressor gene PINX1 and use thereof |
| 01/07/2004 | CN1465703A Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 01/07/2004 | CN1465702A Purifying and use for human vascular endothelial growth factor and granzyme B fusion protein |
| 01/07/2004 | CN1465701A Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 01/07/2004 | CN1465697A Polycondensed amino-acid coordinated SOD simulatives |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465594A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465593A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465592A Human Interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465586A Cyclic Wushengtai and preparation process thereof |
| 01/07/2004 | CN1465399A Lipid reducing and regulating agent |
| 01/07/2004 | CN1465398A External collagenase ointment for treating wound |
| 01/07/2004 | CN1465397A Novel medicine for treating diabetes and chronic complicating disease thereof |
| 01/07/2004 | CN1465396A Anti-tumor medicine |
| 01/07/2004 | CN1465338A Skin activating composition for external used anti-aging preparation |
| 01/07/2004 | CN1133778C Enzymatic wet paper napkin and its production process |
| 01/07/2004 | CN1133743C Modified clotting Factor VII |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/07/2004 | CN1133649C Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 01/07/2004 | CN1133648C Substituted phenylalamine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133463C Pharmaceutical combination preparations containing erythropoietin and iron preparation |
| 01/07/2004 | CN1133462C Methods and compositions for healing and repair of connective tissue attachment |
| 01/07/2004 | CN1133461C Application of tigroid spider toxic extract in preparnig analgesic |
| 01/07/2004 | CN1133460C Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroyfatty acid |
| 01/07/2004 | CN1133437C Nocathiacin antibiotics |
| 01/07/2004 | CN1133433C Nucleoside analogs in combination therapy of herpes simplex infections |
| 01/07/2004 | CN1133431C Treatment of diabetes with rosiglitazone and insulin |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6675048 Electro-medical device for use with biologics |
| 01/06/2004 | US6673986 Transgenic mouse; deactivated endogenous immunoglobulin heavy chain loci; gene expression |
| 01/06/2004 | US6673929 Process for preparing growth hormone secretagogues |
| 01/06/2004 | US6673918 One pot deprotection of preferential nucleotide sequences; obtain nucleotide sequences, incubate with triethylamine at room temperature, incubate with anhydrous triethylamine hydrogen fluoride, heat, recover nucletide sequences |
| 01/06/2004 | US6673917 Antiapoptotic agents for use as viricides and anticarcinogenic agents; autoimmune disorders, and neurodegenerative diseases |
| 01/06/2004 | US6673916 Phospholipase inhibitors |
| 01/06/2004 | US6673915 Nucleic acid encoding monocyte chemotactic protein 4 |
| 01/06/2004 | US6673914 Human tumor-associated gene |
| 01/06/2004 | US6673911 Human polyhomeotic 2 (hph2) acts as an oncogene |
| 01/06/2004 | US6673909 Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy |
| 01/06/2004 | US6673904 Stem cell growth factor-like polypeptides |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673900 Polypeptide hormone-phosphatonin |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673896 Derivatives of soluble T-4 |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673894 Inhibitor of cell proliferation and methods of use thereof |
| 01/06/2004 | US6673893 Leukocyte derived growth factor 2 |
| 01/06/2004 | US6673839 L-acetylcarnitine and somatostatin |
| 01/06/2004 | US6673832 Determining whether a compound alleviates vasoconstriction-independent nerve pain mediated by endothelin-1 |
| 01/06/2004 | US6673822 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/06/2004 | US6673807 Administering compound possessing inhibitory activity on production of nitric oxide and tricyclic macrolide or salt, solvate or hydrate thereof to increase graft survival time in transplantation subject |
| 01/06/2004 | US6673778 Administering transdermally morpholino antisense oligomer to reduce expression of cytochrome p450 enzyme that catalyzes metabolism of drug, by hybridizing to target rna molecule which encodes enzyme, thus inhibiting metabolism of drug |
| 01/06/2004 | US6673777 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 01/06/2004 | US6673775 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/06/2004 | US6673771 Administering inhibitor of tumor necrosis factor related activator induced cytokine/receptor activator of nuclear factor kappa beta ligand, peptide having cyclic portion and exocyclic portions comprising tyrosine or phenylalanine |
| 01/06/2004 | US6673770 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673767 Gel composition and methods |
| 01/06/2004 | US6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673605 Established cell line of microglia |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673580 Genetically engineering thrombopoietin for use in the treatment of thrombocytopenia; obtain polypeptide, adjust epitopes, recover polypeptide, administer to patients |
| 01/06/2004 | US6673575 Use of cultured, recombinant eukaryotic cells in the production of glycoproteins for pharmaceutical use especially given the control in degree of glycosylation afforded by the procedure |
| 01/06/2004 | US6673574 Oral delivery of peptides using enzyme-cleavable membrane translocators |
| 01/06/2004 | US6673570 Smad associating polypeptides |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673559 Met proto-oncogene and a method for predicting breast cancer progression |
| 01/06/2004 | US6673534 Methods for detection of mutations in myostatin variants |